FLEXcon’s Bitar Appointed Chair of AIM North America’s Pharma Working Group
The focus of the Pharma Working Group will be to prepare the pharmaceutical industry for the Drug Supply Chain Security Act, which will go into effect in 2023.
FLEXcon Co., Inc. recently announced that Lori Bitar, Market Development manager, has been appointed by AIM North America to serve as chair of its Pharma Working Group. Bitar’s work at FLEXcon focuses on the growth of pressure-sensitive adhesive materials in the medical device and pharmaceutical markets, both domestically and globally.
The focus of the Pharma Working Group will be to prepare the pharmaceutical industry for the Drug Supply Chain Security Act, which will go into effect in 2023. The act will require that all stakeholders within the U.S. supplying and trading in pharmaceuticals, including manufacturers, repackagers, wholesale distributors, and pharmacies, purchase from licensed suppliers and be able to track and trace using appropriate serial number markings and barcodes imprinted on the lot level packaging. Automatic identification and data capture (AIDC) technologies will be used to ensure traceability and allow for the establishment of an interoperable system by the deadline date of November 28, 2023.